BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6427028)

  • 21. High stability hybrids producing monoclonal antibodies against human C-reactive protein.
    Iturralde M; Coll J
    Rev Esp Fisiol; 1984 Sep; 40(3):279-87. PubMed ID: 6522796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and characterization of monoclonal antibodies to bovine immunoglobulin G2.
    Srikumaran S; Guidry AJ; Goldsby RA
    Am J Vet Res; 1982 Jan; 43(1):21-5. PubMed ID: 7091814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of plasma protein fractions as serum substitutes for in vitro cell culture.
    MacLeod AJ; Thomson MB
    Dev Biol Stand; 1985; 60():55-61. PubMed ID: 4043543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice.
    Fishwild DM; O'Donnell SL; Bengoechea T; Hudson DV; Harding F; Bernhard SL; Jones D; Kay RM; Higgins KM; Schramm SR; Lonberg N
    Nat Biotechnol; 1996 Jul; 14(7):845-51. PubMed ID: 9631008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies.
    Stadler BM; Berenstein EH; Siraganian RP; Oppenheim JJ
    J Immunol; 1982 Apr; 128(4):1620-4. PubMed ID: 6977565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiotypic analysis of anti-I-Ak monoclonal antibodies. I. Production and characterization of syngeneic anti-idiotypic mAb against an anti-I-Ak mAb.
    Phillips ML; Harris JF; Delovitch TL
    J Immunol; 1984 Nov; 133(5):2587-94. PubMed ID: 6434633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine hybridomas secreting monoclonal antibodies reacting with Mlsa antigens.
    Di Giorgi L; De Matos C; Ellis BA; Matossian-Rogers A
    Exp Clin Immunogenet; 1993; 10(4):219-23. PubMed ID: 8136179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Production and characterization of monoclonal antibodies against allergen components].
    Petersen A; Kahlert H; Jelke H; Becker WM; Schlaak M
    Immun Infekt; 1989 Oct; 17(5):158-64. PubMed ID: 2479598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth kinetics of hybridoma cells: (1) The effects of varying foetal calf serum levels.
    Low K; Harbour C
    Dev Biol Stand; 1985; 60():17-24. PubMed ID: 4043533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preparation and identification of monoclonal antibodies against Type M/N and Glycophorin A/B].
    Chen Q; Cao H; Zhang HY; Gao XF; Wang F; Li HD
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):556-8. PubMed ID: 17553354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains.
    Lowe J; Hardie D; Jefferis R; Ling NR; Drysdale P; Richardson P; Raykundalia C; Catty D; Appleby P; Drew R; Maclennan IC
    Immunology; 1981 Apr; 42(4):649-59. PubMed ID: 6786981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning, characterization, and modeling of a monoclonal anti-human transferrin antibody that competes with the transferrin receptor.
    Orlandini M; Santucci A; Tramontano A; Neri P; Oliviero S
    Protein Sci; 1994 Sep; 3(9):1476-84. PubMed ID: 7530542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of monoclonal antibodies against Taylorella equigenitalis.
    Gradinaru DA; Helmer JM; Klein F
    Vet Res; 1997; 28(1):65-76. PubMed ID: 9172842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies to the amino- and carboxyl-terminal domains of human transferrin.
    Mason AB; Woodworth RC
    Hybridoma; 1991 Oct; 10(5):611-23. PubMed ID: 1725170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One step generation of fully chimeric antibodies using Cgamma1- and Ckappa mutant mice.
    Jensen M; Klehr M; Vogel A; Schmitz S; Tawadros S; Mühlenhoff M; Plück A; Fischer T; Schomäcker K; Schultze JL; Berthold F
    J Immunother; 2007 Apr; 30(3):338-49. PubMed ID: 17414325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-specific human antibodies from mice comprising four distinct genetic modifications.
    Lonberg N; Taylor LD; Harding FA; Trounstine M; Higgins KM; Schramm SR; Kuo CC; Mashayekh R; Wymore K; McCabe JG
    Nature; 1994 Apr; 368(6474):856-9. PubMed ID: 8159246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse.
    Kametani Y; Shiina M; Katano I; Ito R; Ando K; Toyama K; Tsukamoto H; Matsumura T; Saito Y; Ishikawa D; Taki T; Ito M; Imai K; Tokuda Y; Kato S; Tamaoki N; Habu S
    Exp Hematol; 2006 Sep; 34(9):1240-8. PubMed ID: 16939817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation and characterization of monoclonal antibody against human LSECtin].
    Du XM; Tang L; Liu XL; Chen Y; Gao JE; He FC; Sun QH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):517-20. PubMed ID: 16806021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and characterization of monoclonal antibodies against bovine luteinizing hormone.
    Kofler R; Kalchschmid E; Berger P; Wick G
    Immunobiology; 1981; 160(2):196-207. PubMed ID: 7319540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.